Sycamore Labs | $65,000,000 | (Mar 31, 2026)
Deccan AI | $25,000,000 | (Mar 31, 2026)
Stedi | $50,000,000 | (Mar 31, 2026)
mo:re
Germany
- Hamburg
- 01/04/2025
- Seed
- $2,485,277
Your new teammate in the lab! Our lab platform takes over tedious and error-prone manual tasks in 3D cell culture, aiming to replace animal studies. A standardised repository of protocols lets you set up new experiments within minutes. Our AI-based quality control provides real-time transparency on the state of your cell culture, allowing you to worry less and make well-informed decisions.
- Industry Biotechnology Research
- Website https://more.science/
- LinkedIn https://www.linkedin.com/company/more-lifesciences/
Related People
Lukas GaatsFounder
Germany -
Hamburg, Hamburg
Co-founder & CEO of mo:re, a biotechnology start-up building the new gold standard for organoid-based drug development by offering a lab platform that industrialises cell culture workflows.
Our platform of a lab robot and software replaces animal studies with AI-assisted cultivation of disease models on which new compounds can be tested in a standardised and high-throughput fashion. This enables scaling up experiments without compromising traceability and quality to bridge the gap between PoC and industry experiments.
Visit mo:re https://more.science
OpenBox AI | $5,000,000 | (Mar 31, 2026)
Qodo | $70,000,000 | (Mar 31, 2026)
Starcloud | $170,000,000 | (Mar 31, 2026)
Valinor(1) | $25,000,000 | (Mar 31, 2026)
Mars Men | $27,500,000 | (Mar 31, 2026)
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)